Top promising pipeline drugs for chronic hepatitis B, 2014, by sales

Published by Statista Research Department, Jan 1, 2016
This statistic shows the top promising pipeline drugs globally for chronic hepatitis B in 2014 , by peak year sales. The peak year sales of GS-9620 (Gilead Science) drug for chronic hepatitis B was almost 385 million US dollars in the year 2014.

Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2016

Region

Worldwide

Survey time period

as of November 2014

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Healthcare in Hungary "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Healthcare in Hungary

Overview

6

Physicians and hospitals

8

Health insurance and private healthcare

7

State of health

6

Diseases

8

MedTech and digital health

8

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Hepatitis in the U.S.Alcohol and healthDiseasesOrgan donations and transplantsDrug use in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.